Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Novartis vows to fight U.S. price-fixing claims against Sandoz unit

Novartis said claims of price fixing against the drugmaker’s Sandoz generics unit amid a U.S. probe of 20 drugmakers are without merit, with the Swiss company vowing to fight allegations in a lawsuit.

Read More »

U.S. appeals court upholds ruling invalidating J&J patent on Remicade

A U.S. appeals court upheld a ruling that invalidated a crucial J&J patent on its blockbuster rheumatoid arthritis drug Remicade.

Read More »

Shire sues Allergan in U.S. over dry eye drug

Allergan Plc was sued by Shire Plc for allegedly scheming to block doctors from prescribing its new treatment for dry eye disease.

Read More »

$100 Million FTC Settlement for Mallinckrodt ARD

Mallinckrodt ARD Inc. will pay $100 million to settle federal complaints the company violated antitrust laws after acquiring the rights to an ACTH drug.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom